News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,797 Results
Type
Article (13810)
Company Profile (101)
Press Release (251886)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88070)
Career Advice (465)
Deals (15345)
Drug Delivery (67)
Drug Development (36609)
Employer Resources (49)
FDA (6302)
Job Trends (6202)
News (150265)
Policy (14043)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (33)
Alliances (23230)
ALS (36)
Alzheimer's disease (393)
Antibody-drug conjugate (ADC) (41)
Approvals (6338)
Artificial intelligence (107)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (20)
Brain cancer (16)
Breast cancer (78)
Cancer (612)
Cardiovascular disease (72)
Career advice (408)
Career pathing (12)
CAR-T (22)
Cell therapy (88)
Cervical cancer (4)
Clinical research (30932)
Collaboration (344)
Compensation (155)
Complete response letters (17)
COVID-19 (757)
CRISPR (20)
C-suite (124)
Cystic fibrosis (37)
Data (639)
Denatured (15)
Depression (9)
Diabetes (81)
Diagnostics (1319)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (65)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (32147)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37516)
Executive appointments (392)
FDA (6723)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (215)
Gene editing (38)
Generative AI (9)
Gene therapy (100)
GLP-1 (349)
Government (1299)
Grass and pollen (3)
Guidances (16)
Healthcare (3565)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (14)
Infectious disease (792)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (47)
Interviews (59)
IPO (5878)
IRA (29)
Job creations (2052)
Job search strategy (373)
Kidney cancer (6)
Labor market (12)
Layoffs (180)
Leadership (3)
Legal (3433)
Liver cancer (19)
Lung cancer (82)
Lymphoma (55)
Machine learning (1)
Management (16)
Manufacturing (158)
MASH (32)
Medical device (1276)
Medtech (1278)
Mergers & acquisitions (9675)
Metabolic disorders (262)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (578)
NextGen: Class of 2025 (1586)
Non-profit (593)
Northern California (712)
Now hiring (8)
Obesity (150)
Opinion (119)
Ovarian cancer (21)
Pain (51)
Pancreatic cancer (14)
Parkinson's disease (46)
Partnered (7)
Patents (117)
Patient recruitment (29)
Peanut (10)
People (28967)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8048)
Phase II (13089)
Phase III (11743)
Pipeline (445)
Policy (71)
Postmarket research (1401)
Preclinical (3220)
Press Release (25)
Prostate cancer (46)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (168)
Real estate (2637)
Recruiting (17)
Regulatory (10120)
Reports (14)
Research institute (565)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (37)
Series B (13)
Service/supplier (3)
Sickle cell disease (32)
Southern California (726)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1629)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (26)
The Weekly (30)
United States (7261)
Vaccines (153)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (3)
Date
Today (78)
Last 7 days (202)
Last 30 days (907)
Last 365 days (11811)
2025 (3625)
2024 (12502)
2023 (14246)
2022 (19557)
2021 (20071)
2020 (19037)
2019 (14889)
2018 (11715)
2017 (13889)
2016 (13130)
2015 (15473)
2014 (12419)
2013 (10594)
2012 (11398)
2011 (11924)
2010 (10889)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (55)
Arkansas (3)
Asia (20131)
Australia (2615)
California (1730)
Canada (911)
China (239)
Colorado (69)
Connecticut (68)
Delaware (56)
Europe (39458)
Florida (329)
Georgia (38)
Idaho (9)
Illinois (196)
India (16)
Indiana (135)
Iowa (1)
Japan (93)
Kansas (57)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (258)
Massachusetts (1496)
Michigan (30)
Minnesota (95)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (769)
New Mexico (7)
New York (513)
North Carolina (395)
North Dakota (2)
Northern California (712)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (445)
Puerto Rico (8)
Rhode Island (10)
South America (502)
South Carolina (2)
Southern California (726)
Tennessee (34)
Texas (233)
Utah (33)
Virginia (76)
Washington D.C. (31)
Washington State (119)
Wisconsin (16)
265,797 Results for "corvus pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors
April 10, 2025
·
4 min read
Press Releases
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
March 25, 2025
·
20 min read
Press Releases
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
April 23, 2025
·
2 min read
Press Releases
Corvus Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
March 20, 2025
·
1 min read
Press Releases
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
March 17, 2025
·
1 min read
Press Releases
Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of Soquelitinib for Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)
March 12, 2025
·
9 min read
Press Releases
Corvus Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
1 min read
Press Releases
Corvus Pharmaceuticals Announces Presentation of Additional Data from the Phase 1/1b Clinical Trial of Soquelitinib for Patients with T Cell Lymphoma
March 20, 2025
·
9 min read
Press Releases
Corvus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Business
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS) (GLOBAL NEWSWIRE), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the first quarter ended March 31, 2024.
May 6, 2024
·
19 min read
1 of 26,580
Next
